ATP2A3 and COVID-19: Our sensitivity analyses confirmed the robustness of the association between 14 out of 15 blood markers and hospitalized-COVID-19, with ATP2A3 not satisfying the sensitivity analysis criteria (see S4 and S5 Tables, for a full breakdown of these sensitivity analyses).